Humacyte, Inc. (HUMA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Humacyte, Inc. reported revenue of $2.04M. The company ran a net loss, with a net margin of -2003.6%. It held $116.37M in total assets against $113.26M in total liabilities.
Key ratios (FY2025)
-5306.0%
Operating margin
-2003.6%
Net margin
-1313.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.04M | $0 | — | — | — | — | — |
| Cost of Revenue | $9.70M | $0 | — | — | — | — | — |
| Operating Income | -$108.14M | -$114.40M | -$100.05M | -$84.58M | -$81.21M | -$64.60M | — |
| Net Income | -$40.83M | -$148.70M | -$110.78M | -$11.96M | -$26.48M | -$66.52M | — |
| EPS (Diluted) | $-0.26 | $-1.26 | $-1.07 | $-0.12 | $-0.66 | $-11.54 | — |
| Total Assets | $116.37M | $137.87M | $128.22M | $204.30M | $286.53M | $106.69M | — |
| Total Liabilities | $113.26M | $190.54M | $114.68M | $87.37M | $164.36M | $36.02M | — |
| Shareholders' Equity | $3.11M | -$52.67M | $13.55M | $116.93M | $122.17M | -$350.32M | -$288.79M |
| Cash & Equivalents | $50.50M | $44.94M | $80.45M | $149.77M | $217.50M | $39.93M | — |
| Operating Cash Flow | -$105.04M | -$98.12M | -$73.31M | -$71.13M | -$81.19M | -$55.57M | — |
| Capital Expenditures | $884.0K | $1.57M | $2.28M | $1.05M | $220.0K | $318.0K | — |
| Shares Outstanding | 193.00M | 130.03M | 103.67M | 103.23M | 103.00M | 5.82M | — |